Moreover, many very well proven adverse prognostic markers, which includes U-CLL, ATM aberrations or NOTCH1/BIRC3 mutations, misplaced their negative outcome in people handled with VO. The one variable that remained predictive of a shorter progression-no cost survival Within this cohort of sufferers was TP53 aberrations.112 Lastly, the alternative